Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin‐metformin combination in newly diagnosed Type 2 diabetes

AIM: To assess the long‐term clinical benefits of early combination treatment with vildagliptin‐metformin vs. standard‐of‐care, metformin monotherapy in the ongoing VERIFY study. METHODS: We randomized 2001 participants with multi‐ethnic background, aged 18–70 years, having HbA(1c) levels 48–58 mmol...

Descripción completa

Detalles Bibliográficos
Autores principales: Matthews, D. R., Paldánius, P. M., Proot, P., Foley, J. E., Stumvoll, M., Del Prato, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594102/
https://www.ncbi.nlm.nih.gov/pubmed/30576013
http://dx.doi.org/10.1111/dme.13886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594102/
https://www.ncbi.nlm.nih.gov/pubmed/30576013
http://dx.doi.org/10.1111/dme.13886

Ejemplares similares